NEWTON LOWER FALLS, MASS. -- VetCentric, an Annapolis, Md.-based prescription drug distribution company serving the veterinary marketplace, has secured $14.5 million in a Series B round of financing.
Newton Lower Falls, Mass.-based Sherbrooke Capital, a new investor, provided $4 million for the round, co-leading the financing with Three Arch Capital, an existing VetCentric shareholder.
Other previous VetCentric investors taking part in the latest round were Asset Management, the Aurora Funds, Staenberg Private Capital, and Vantage Venture Partners.
VetCentric provides veterinary-focused pharmacy services, including home delivery of prescription medications and therapeutic diets to pet owners on behalf of veterinarians.
Proceeds from the round will be devoted to marketing of its products, as well as to establishing partnerships with national animal healthcare providers. The new funds will also go towards the upgrade of systems and infrastructure.
Back to Portfolio News